DLB · XBRL financial data

Dolby Laboratories financial statements, every fiscal year

The same tables from 6 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (DLB's year ends in late September)

In millions of dollars	FY 2020Sep 25, 2020	FY 2021Sep 24, 2021	FY 2022Sep 30, 2022	FY 2023Sep 29, 2023	FY 2024Sep 27, 2024	FY 2025Sep 26, 2025
Revenue	1,162	1,281	—	—	—	—
Revenue from contracts with customers	1,162	1,281	1,254	1,300	1,274	1,349
Cost of revenue	146	130	141	153	140	160
Gross profit	1,015	1,151	1,112	1,147	1,133	1,189
Research and development	239	254	261	272	264	262
General and administrative	220	224	275	258	270	287
Total operating expenses	797	807	906	931	875	924
Operating income (loss)	219	344	207	216	258	265
Interest income	13	3	7	—	—	—
Interest expense	0	0	0	—	—	—
Other income (expense)	8	7	3	6	20	23
Income tax expense (benefit)	8	37	31	48	48	47
Net income (loss)	231	310	184	201	262	255
Earnings per share, basic USD per share	2.30	3.07	1.84	2.10	2.74	2.66
Earnings per share, diluted USD per share	2.25	2.97	1.81	2.05	2.69	2.62
Weighted average shares, basic millions of shares	101	101	100	96	96	96
Weighted average shares, diluted millions of shares	103	105	102	98	97	97

Fiscal years (DLB's year ends in late September)

In millions of dollars	FY 2020Sep 25, 2020	FY 2021Sep 24, 2021	FY 2022Sep 30, 2022	FY 2023Sep 29, 2023	FY 2024Sep 27, 2024	FY 2025Sep 26, 2025
Cash and cash equivalents	1,072	1,225	620	745	482	702
Short-term investments	47	39	189	139	0	1
Marketable securities, non-current	—	63	103	98	89	—
Accounts receivable	180	233	244	262	315	331
Inventory	26	11	24	36	34	30
Prepaid and other current assets	53	63	50	51	70	52
Total current assets	1,547	1,760	1,311	1,488	1,194	1,388
Property and equipment, net	542	534	513	482	479	471
Right-of-use asset	77	67	47	40	39	33
Goodwill	337	341	365	408	533	530
Total assets	2,917	3,106	2,690	2,980	3,110	3,228
Accounts payable	13	18	14	21	17	18
Accrued liabilities	220	263	230	351	348	369
Total current liabilities	267	316	278	422	418	438
Lease liability, non-current	65	57	38	37	35	28
Total liabilities	479	501	439	608	623	596
Retained earnings	2,443	2,608	2,298	2,392	2,496	2,635
Total stockholders' equity	2,433	2,598	2,246	2,355	2,477	2,623
Total liabilities and equity	2,917	3,106	2,690	2,980	3,110	3,228

Fiscal years (DLB's year ends in late September)

In millions of dollars	FY 2020Sep 25, 2020	FY 2021Sep 24, 2021	FY 2022Sep 30, 2022	FY 2023Sep 29, 2023	FY 2024Sep 27, 2024	FY 2025Sep 26, 2025
Net income (loss)	231	310	184	201	262	255
Stock-based compensation	87	100	115	118	120	129
Net cash from operating activities	344	448	319	367	327	472
Purchases of property and equipment	66	54	48	30	30	36
Net cash from investing activities	134	(45)	(296)	54	(286)	(11)
Share repurchases	174	246	530	149	160	125
Dividends paid	89	89	100	103	115	127
Net cash from financing activities	(208)	(253)	(611)	(237)	(288)	(247)
Net change in cash	274	153	(605)	190	(240)	216

SIC 6794 and related industry codes, similar size. Each row is the latest quarter reported.

How peers are chosen

SIC 6794 and related industry codes with public float (or, where float is missing, quarterly revenue) between 0.2x and 5x the company's.
Each row is the latest quarter the company has reported, named in the Quarter column; when that filing is a 10-K, it is the fourth quarter, never the full year.
* marks a quarter worked out from the filing totals: for a 10-Q, the year-to-date total less the earlier one.
A cell reading “not reported” means the filings give no figure for that quarter alone.

Company	Cash ($M)	Revenue, quarter ($M)	Operating cash flow, quarter ($M)	Shares outstanding	Quarter
Dolby Laboratories	669	305	167*	not reported	Q3 FY26 10-QJun 26, 2026
Broadstone Net Lease	12	122	88*	192.0M	Q3 FY26 10-QSep 30, 2026
Potlatchdeltic	89	314	66*	77.3M	Q3 FY25 10-QSep 30, 2025
Lineage	58	1,361	311*	227.7M	Q2 FY26 10-QJun 30, 2026
National Health Investors	30	121	65*	49.1M	Q2 FY26 10-QJun 30, 2026
Blackstone Mortgage Trust	512	not reported	(18)*	166.0M	Q3 FY26 10-QSep 30, 2026
HA Sustainable Infrastructure Capital	250	121	68*	128.5M	Q2 FY26 10-QJun 30, 2026
Highwoods Properties	279	218	not reported	110.3M	Q3 FY26 10-QSep 30, 2026
Four Corners Property Trust	7.2	8	61*	109.8M	Q3 FY26 10-QSep 30, 2026

Not investment advice. Not affiliated with the U.S. SEC.